Heavy blast! Wuhan Emergency Notice All Nucleic Acid Screening Tests! Ten days of battle to detect 10 million people? Three types of districts are the focus of research | Mike Bio-Finance News



[ad_1]

Original title: Heavy Burst! Wuhan Emergency Notice All Nucleic Acid Screening Tests! Ten days of battle to detect 10 million people? The focus of the investigation of the three types of community source: China Fund News

After 6 consecutive confirmed cases were added to a community in Wuhan on Day 2, Wuhan urgently started nucleic acid screening of all staff!

On May 11, a “Urgent Notice from Wuhan on the completion of the city’s new coronavirus nucleic acid detection” (hereinafter, the “Notice”) flowed, and after investigation, it was decided to carry out Nucleic Acid Detection of Novel Corona Virus Within Wuhan City for “Ten Days” Battle of the General Assembly. ”The notice requires all districts to make a nucleic acid detection plan for all personnel within their jurisdiction within a 10-day period. Statistics show that Wuhan has a permanent population of over 11 million.

Later, Peng Mei News confirmed this news from the epidemic prevention and control headquarters in many Wuhan districts.

Today, companies listed on the A-share epidemic detection list have resisted the trend and closed as of the morning.Mike Bio,Master BioAfter the shares skyrocketed, the new coronary pneumonia test rate increased 2.56%.

Wuhan emergency notice!

11 million nucleic acid detection in 10 days

On May 11, an “Emergency Announcement on the Conduct of New City Crown Virus Nucleic Acid Detection” was posted online in Wuhan.

Among them, the headquarters of the Coronary Pneumonia Epidemic Prevention and Control headquarters in Wuhan was informed that, following an investigative decision, a “ten-day battle” for nucleic acid detection will be conducted for all new coronaviruses in Wuhan. Each district will make the nucleic acid detection plan arrangements for all personnel in its jurisdiction within a 10 day period.

The notice stated that each district is responsible for normalizing the epidemic prevention and control requirements according to the size of the district population under its jurisdiction, and specifying the specific implementation plan in light of the actual situation of the district. The plan should clarify the basic situation, the method of organization, the schedule and other matters of the jurisdiction. The implementation plan must be returned to the designated mailbox in the form of a red header file by 12 noon on May 12.

In the “Notice” notice, nucleic acid detection should highlight key points to ensure priority coverage of key populations and key areas. Ancient areas, densely populated areas, and concentrated floating population areas should be the focus of the research. The scope of the investigation should include permanent residents and residents of the jurisdiction. Floating population.

On the morning of the 12th, Peng Mei News confirmed this news from the epidemic prevention and control headquarters in many districts of Wuhan. Currently, all districts have formulated implementation plans according to the requirements of the documents and according to the situation in the district.

According to official statistics from the Wuhan Municipal Statistical Office, in 2018, the permanent population of Wuhan was 11,081 million. Previously, the Wuhan Municipal Health Commission issued a message that as of 24:00 on April 29, Wuhan City had performed 1.0344 million nucleic acid tests.

6 cases were confirmed on the 2nd day

Break the previous 35 days without a new record

On May 9-10, Wuhan added a total of 6 new confirmed cases of new pneumonia, breaking the 35-day record of no new confirmed cases in Hubei province.

According to the notification from the Wuhan Municipal Health Commission, the six new cases are living in the Sanmin community, Changqing Street, Dongxihu District, Wuhan City, of which there are two couples.

There were 20 confirmed cases in this community and, after expert analysis, there were conditions for community infection. Sanmin Community is understood to be an old semi-closed and open community. There are more than 4,900 people in 1,943 households in the community, and almost half of the residents are foreign tenants.

According to a notification on May 7, Gao Moumou had a history of hypertension, stroke and liver cysts, and had not left the community after the Spring Festival. Symptoms like fever and chills appeared on March 17. After taking medications at home for 10 days, the symptoms disappeared without medical treatment. On April 15, the patient developed symptoms of poor appetite and mental anguish.

On May 6, Gao XX was accompanied by community personnel and wore a mask throughout the process to perform nucleic acid tests at the Dongxihu District Maternal and Child Health Hospital. On May 7, the nucleic acid test showed positive results and the serum antibodies showed positive IgG. On May 9, the reexamination antibody was positive, and after careful expert discussion, it was confirmed as a confirmed case of new coronary pneumonia.

After Gao Moumou was diagnosed, residents of the Sanmin community were screened for nucleic acids the same day, and 5 asymptomatic infections were found on examination. Implement centralized isolation and nucleic acid detection for key populations and close contacts as soon as possible. The report says there were 20 confirmed cases in the patient’s residential area. After the organization’s experts investigated and analyzed various factors, the cause should primarily be previous community infection.

It is worth noting that on the morning of May 11, the official website of the Dongxihu District Government announced that due to poor control of the Sanmin community on Changqing Street, many new cases have been confirmed in recent days. coronary pneumonia. Secretary of the Qingjie Working Committee of the East-West Lake Committee of the Communist Party of China.

Secretary of the Wuhan Municipal Committee:

Widely extend the scope of nucleic acid detection,

According to the Changjiang Daily, on May 11, Wang Zhonglin, a member of the Standing Committee of the Hubei Provincial Party Committee and Secretary of the Wuhan Municipal Party Committee, chaired the video dispatch meeting of the Epidemic Prevention and Control Headquarters of Coronary pneumonia to analyze problems in the prevention and control of the East and West Lakes Region and normalize the city. The epidemic prevention and control work was mobilized, deployed and implemented. The report mentions that there is a need to comprehensively expand the scope of testing and focus on testing operations.

“We must deeply understand that decisive achievements do not mean decisive victory, and that the degradation of the emergency response does not mean the degradation of defense, and we must not be careless, paralyzed and lax,” said Wang Zhonglin.

New crown detection sector fires

This morning, the new coronary pneumonia monitoring plate increased and the rate increased by more than 3%. At the close of the morning, the index increased by 2.56%. Among them, Mike Bio and Master’s Bio daily limit increased by more than 9%.Mingde Biology,Daan Gene,BGIOther shares also rose one after another.

according toIndustrial valuesAccording to incomplete statistics, there are almost a thousand national companies dedicated to R&D and the production of products related to the new crown tests, of which more than 160 have obtained CE certification.

Among the more than 40 companies that have obtained nucleic acid detection products from the US FDAEUA. In the USA, there are four Chinese companies: BGI, Nanjing Coves, Mike Bio,Fosun PharmaAmong them, the only companies that have obtained the national NMPA registration, the EU CE certification and the US FDAEUA. USA They are Huada Gene, Mike Biology and Fosun Pharma.

In addition, on April 23, the Hubei Office of Medical Security issued a plan to begin the centralized acquisition of new detection reagents related to the coronavirus.

The new collection of crown detection kits from Hubei Province is planned to be selected by companies including nucleic acid detection reagent companies Mike Biology, Da’an Gene, Mingde Biology, BGI (Wuhan) and companies from antibody detection reagentsLivzon GroupNovozymes, the price of nucleic acid detection varies from 16.78-24.99 yuan / person, the price of antibody detection is 12.99 yuan / person and 13.885 yuan / person.

Brokerage:

Nucleic Acid Detection Market Has Reached 5.2 Billion

Tianfeng SecuritiesThe research report shows that China will continue to strengthen the detection of new coronaviruses, including hospitalized patients, routine emergency and outpatient services, and the return to the population. Neutral estimate, the new coronavirus nucleic acid detection market in China is 5.2 billion, and antibody detection is 3.4 billion. The epidemic situation abroad is still in a period of tension, and the demand for kits is relatively large. According to a neutral estimate, about 130 million people abroad should be tested for new coronaviruses, the corresponding nucleic acid detection market space is 12.6 billion, and the antibody detection market space is of 2.5 billion.

According to the calculation of the demand for new crown detection kits at home and abroad, Societe Generale Securities has a domestic market of more than 20 billion yuan.

Domestic: The epidemic has entered the normalization stage and needs to be prepared for a protracted battle. 4 types of people are supposed to be performed: all hospitalization tests in the hospital, all tests of entry abroad, all tests of reincorporation and re-entry, and voluntary tests by staff in the country. New Crown Testing’s market size is approximately 14.759 trillion yuan.

Foreign countries: Select countries with more than 5,000 diagnoses currently for analysis. Developed and developing countries are measured separately for the amount of test reagents required during the epidemic. At the same time, standardized tests are also calculated after the epidemic has gradually improved.

The final prediction is that, under the hypothetical scenario of different numbers of diagnoses, the new size of the global market (except China) totals between US $ 1,078 billion and US $ 1.90 billion.

Related National Listed Companies: Companies with approved related products such asWanfu Bio,Antu BioDaan GeneKehua Bio, Shuo Shi Biology, Ming De Biology,For life,Lepu Medical, Livzon Group, etc. Among them, companies that have achieved the national NMPA registration, the EU CE certification and the US FDAEUA: BGI, Mike Bio, Fosun Pharma. Companies that provide new crown testing services such asGolden Field Medicine,Dean Diagnostics,Cap BioWait.

Shanghai Securities stated that the joint prevention and control mechanism requires that all third-tier hospitals have the ability to independently perform new coronavirus tests; disease control and conditional specialized hospitals at all levels, second-tier hospitals and independently established medical testing laboratories should improve their detection capabilities. Recently, the Health and Health Commission issued a document to further improve the requirements, and hospitals above the second level should develop testing capabilities in a short time. Standardized prevention and control require large-scale testing. The epidemic situation abroad is severe, and demand for testing of related products has been high. It is beneficial for national and international channels with soft channels, related test listing companies and third party testing institutions with testing capabilities.

However, Wanlian Securities said in the short term: Due to epidemic factors and the comparative advantages of industry performance that have been put into play, institutional positions have remained relatively high, and the pharmaceutical sector as a whole may continue to hold strong performance in the future. Sexuality is not excellent, but the short-term epidemic situation will not change the medium and long-term logic of the industry’s own operation. In the second quarter, medical institutions have basically restored the order of diagnosis and treatment, and the construction of new infrastructure in the medical industry is expected to accelerate. Varieties can still be assigned on medium to long-term dives.

[ad_2]